Research Peptide

PT-141 10mg

Melanocortin receptor agonist (MC3R/MC4R) — synthetic cyclic heptapeptide Structural derivative of α-MSH analog Melanotan II with distinct receptor selectivity Research-grade · CAS 189691-06-3 For in vitro melanocortin receptor research only

$39.99 In stock
Research-Grade CompoundsManufactured to research-grade standards for laboratory research use only.
Discreet ShippingEvery order ships in plain, protective packaging.
In-House FulfillmentOrders are inspected, packed, and shipped directly by the Heritage Labs team.
Same-day dispatch on orders before 12:00 PM ET, Mon–Fri. Discreet, plain packaging.
In-House Fulfillment Orders are inspected, packed, and shipped directly by the Heritage Labs team.
View this compound’s Certificate of Analysis →
SSL 256-bit Secure Checkout

For laboratory research use only. Not for human or veterinary consumption. SKU P41.

Overview

Product details.

PT-141 10mg — Bremelanotide
PT-141 began its life as a derivative of Melanotan II but ended up somewhere unexpected. By removing the C-terminal amide from its parent compound, researchers created a cyclic heptapeptide with a shifted melanocortin receptor selectivity profile — one that preferentially engages MC3R and MC4R subtypes in hypothalamic regions rather than acting peripherally. The result, documented by Pfaus et al. in PNAS (2004), is a compound that triggers downstream dopamine release through central nervous system melanocortin pathways (PubMed 15226502).
Research-Grade Compounds
Manufactured to research-grade standards for laboratory research use only.
Discreet Shipping
Every order ships in plain, protective packaging.
In-House Fulfillment
Orders are inspected, packed, and shipped directly by the Heritage Labs team.

Specifications

Sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Molecular Formula C50H68N14O10
Molecular Weight 1025.18 g/mol
CAS Number 189691-06-3
Classification MC3R/MC4R melanocortin receptor agonist
Form Lyophilized powder
Quantity 10mg per vial

The melanocortin angle

MC3R sits primarily in the hypothalamus and is associated with energy homeostasis research. MC4R is involved in appetite regulation, energy expenditure, and reproductive function in preclinical models. PT-141 hits both. Thurston et al. used fMRI to document amplified cerebellar/motor area activity and amygdala-insula functional connectivity during controlled stimulus paradigms in MC4R agonism studies (J Clinical Investigation, 2022; PubMed 36194485).

Structurally, the compound features a norleucine substitution at the N-terminus and a constrained cyclic core via a lactam bridge — giving it defined conformational stability and consistent receptor-binding characteristics in analytical work.

PT-141 vs Melanotan II

Same cyclic core, different receptor profile. Removing the C-terminal amide changes how the peptide interacts with MC3R and MC4R in competitive binding assays. PT-141 research has concentrated on central melanocortin pathway activation, while Melanotan II research covers a broader receptor spectrum.

Frequently paired with

  • Selank 5mg — Complementary neuropeptide research.

Quality and testing

Every Heritage Labs compound is manufactured to research-grade standards and shipped in protective packaging.

Storage

  • Lyophilized: -20°C
  • Reconstituted: 2-8°C, use within 30 days
  • Protection: Shield from light and moisture; avoid freeze-thaw cycles

References

  1. Pfaus JG, et al. PNAS. 2004;101(27):10201-10204. PubMed 15226502
  2. Mulhall JP, et al. J Urology. 2001;166(4):628-634.
  3. Shabsigh R, et al. J Sexual Medicine. 2006;3(4):628-636.
  4. Thurston L, et al. J Clinical Investigation. 2022;132(19):e152341. PubMed 36194485
  5. Haskell-Luevano C, et al. Nature. 2001;410:1139-1143.

For laboratory research use only. Not for human or veterinary use.

For laboratory research use only. Not for human or veterinary use. This product is not a drug or supplement and is not intended to diagnose, treat, cure, or prevent any disease.
FDA DISCLAIMER: All products are intended for research use only as defined by the FDA. Not for use in diagnostic procedures, human use, or veterinary use. Products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. All products sold by Heritage Labs are intended strictly for laboratory research, analytical, or in-vitro purposes only. Heritage Labs operates as a chemical supplier and is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Additionally, Heritage Labs is not classified as an outsourcing facility under Section 503B of the same Act. The statements on this website have not been evaluated by the U.S. Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.
Loading...